{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T07:20:58Z","timestamp":1794986458504,"version":"4.9.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijcrp.2026.200717","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:53:41Z","timestamp":1791330821000},"page":"200717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Renal denervation beyond resistant hypertension: should drug intolerance redefine eligibility?"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5502-542X","authenticated-orcid":false,"given":"Elena-Mihaela","family":"Cordeanu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Morisot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Mirea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Prinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Bronner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Stephan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcrp.2026.200717_bib1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","author":"Ncd","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ijcrp.2026.200717_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ijcrp.2026.200717_bib3","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/CIRCRESAHA.118.313220","article-title":"Adherence in hypertension: a review of prevalence, risk factors, impact, and management","volume":"124","author":"Burnier","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcrp.2026.200717_bib4","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/HJH.0000000000002398","article-title":"Nonadherence to antihypertensive medications is related to pill burden in apparent treatment-resistant hypertensive individuals","volume":"38","author":"Lawson","year":"2020","journal-title":"J. Hypertens."},{"issue":"17","key":"10.1016\/j.ijcrp.2026.200717_bib5","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.3390\/jcm14176218","article-title":"Multiple drug intolerance syndrome and arterial hypertension\u2014systematic review and meta-analysis","volume":"14","author":"Rusinek","year":"2025","journal-title":"JCM"},{"key":"10.1016\/j.ijcrp.2026.200717_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2025-326186","article-title":"Renal denervation in 2026: trial evidence, guideline recommendations and implementation strategies for clinical practice","author":"Sesa-Ashton","year":"2026","journal-title":"Heart"},{"key":"10.1016\/j.ijcrp.2026.200717_bib7","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1161\/CIRCRESAHA.121.318091","article-title":"Device therapy of hypertension","volume":"128","author":"Mahfoud","year":"2021","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.ijcrp.2026.200717_bib8","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"Mancia","year":"2023","journal-title":"J. Hypertens."},{"issue":"38","key":"10.1016\/j.ijcrp.2026.200717_bib9","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur. Heart J."},{"issue":"0","key":"10.1016\/j.ijcrp.2026.200717_bib10","volume":"0","author":"Jones","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.ijcrp.2026.200717_bib11","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/HYPERTENSIONAHA.116.08729","article-title":"Risk factors for nonadherence to antihypertensive treatment","volume":"69","author":"Gupta","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcrp.2026.200717_bib12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/eurheartj\/ehu441","article-title":"Predictors of blood pressure response in the SYMPLICITY HTN-3 trial","volume":"36","author":"Kandzari","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcrp.2026.200717_bib13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jamacardio.2023.0338","article-title":"Patient-level pooled analysis of ultrasound renal denervation in the sham-controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO trials","volume":"8","author":"Kirtane","year":"2023","journal-title":"JAMA Cardiol."},{"issue":"8","key":"10.1016\/j.ijcrp.2026.200717_bib14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/jama.2023.0713","article-title":"RADIANCE II investigators and collaborators. Endovascular ultrasound renal denervation to treat hypertension: the RADIANCE II randomized clinical trial","volume":"329","author":"Azizi","year":"2023","journal-title":"JAMA"},{"issue":"10137","key":"10.1016\/j.ijcrp.2026.200717_bib15","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/S0140-6736(18)31082-1","article-title":"Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial","volume":"391","author":"Azizi","year":"2018","journal-title":"Lancet"},{"issue":"10234","key":"10.1016\/j.ijcrp.2026.200717_bib16","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/S0140-6736(20)30554-7","article-title":"Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial","volume":"395","author":"B\u00f6hm","year":"2020","journal-title":"Lancet"},{"issue":"10137","key":"10.1016\/j.ijcrp.2026.200717_bib17","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/S0140-6736(18)30951-6","article-title":"Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-Month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial","volume":"391","author":"Kandzari","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ijcrp.2026.200717_bib18","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.jacc.2023.08.045","article-title":"Safety and efficacy of renal denervation in patients taking antihypertensive medications: SPYRAL HTN-ON MED expansion","volume":"82","author":"Kandzari","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcrp.2026.200717_bib19","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.jacc.2018.12.082","article-title":"Sham-controlled randomized trials of catheter-based renal denervation in patients with hypertension","volume":"73","author":"Sardar","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcrp.2026.200717_bib20","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.jcin.2021.09.020","article-title":"Renal denervation for hypertension: a systematic review and meta-analysis of randomized, blinded, placebo-controlled trials","volume":"14","author":"Ahmad","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcrp.2026.200717_bib21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jacc.2022.11.038","article-title":"10-year outcomes of catheter-based renal denervation in patients with resistant hypertension","volume":"81","author":"Al","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcrp.2026.200717_bib22","doi-asserted-by":"crossref","DOI":"10.1007\/s00392-024-02417-2","article-title":"Ultra-long-term efficacy and safety of catheter-based renal denervation in resistant hypertension: 10-Year follow-up outcomes","author":"Al Ghorani","year":"2024","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ijcrp.2026.200717_bib23","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/eurheartj\/ehad054","article-title":"Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC council on hypertension and EAPCI","volume":"44","author":"Barbato","year":"2023","journal-title":"Eur. Heart J."},{"issue":"10008","key":"10.1016\/j.ijcrp.2026.200717_bib24","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ijcrp.2026.200717_bib25","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/HYP.0000000000000203","article-title":"Medication adherence and blood pressure control: a scientific statement from the American heart association","volume":"79","author":"Choudhry","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcrp.2026.200717_bib26","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(22)01787-1","article-title":"Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 trial","volume":"400","author":"Bhatt","year":"2022","journal-title":"Lancet"},{"issue":"10333","key":"10.1016\/j.ijcrp.2026.200717_bib27","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S0140-6736(22)00455-X","article-title":"Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial","volume":"399","author":"Mahfoud","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijcrp.2026.200717_bib37","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1161\/CIRCULATIONAHA.124.069291","article-title":"Effect of alcohol-mediated renal denervation on blood pressure in the presence of antihypertensive medications: primary results from the TARGET BP I randomized clinical trial","volume":"149","author":"Kandzari","year":"2024","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200717_bib28","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41440-022-01042-8","article-title":"Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-Month results from SPYRAL HTN-ON MED trial","volume":"46","author":"Kario","year":"2023","journal-title":"Hypertens. Res."},{"issue":"42","key":"10.1016\/j.ijcrp.2026.200717_bib29","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1093\/eurheartj\/ehz118","article-title":"Effects of renal denervation on kidney function and long-term outcomes: 3-Year follow-up from the global SYMPLICITY registry","volume":"40","author":"Mahfoud","year":"2019","journal-title":"Eur. Heart J."},{"issue":"23","key":"10.1016\/j.ijcrp.2026.200717_bib30","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1016\/j.jacc.2020.04.036","article-title":"Renal denervation in high-risk patients with hypertension","volume":"75","author":"Mahfoud","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcrp.2026.200717_bib31","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis","volume":"397","author":"Plttc","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200717_bib32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41440-024-01949-4","article-title":"Novel approaches to define responders to interventional treatment in hypertension: insights from the SPYRAL HTN-OFF and HTN-ON MED trials","volume":"48","author":"Schmieder","year":"2025","journal-title":"Hypertens. Res."},{"issue":"12","key":"10.1016\/j.ijcrp.2026.200717_bib33","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1097\/HJH.0000000000000347","article-title":"Hyperresponders vs. nonresponder patients after renal denervation: do they differ?","volume":"32","author":"Persu","year":"2014","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ijcrp.2026.200717_bib34","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ijcrp.2026.200717_bib35","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1097\/HJH.0000000000004117","article-title":"Long-term safety and efficacy of renal sympathetic denervation in comparison to a population-based cohort: a propensity-matching approach","volume":"43","author":"Zeijen","year":"2025","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ijcrp.2026.200717_bib36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4244\/EIJ-D-19-00902","article-title":"Review and meta-analysis of renal artery damage following percutaneous renal denervation with radiofrequency renal artery ablation","volume":"16","author":"Townsend","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcrp.2026.200717_bib38","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/ndt\/gfx088","article-title":"Renal safety of catheter-based renal denervation: systematic review and meta-analysis","volume":"32","author":"Sanders","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ijcrp.2026.200717_bib39","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/eurheartj\/ehx215","article-title":"Proceedings from the 2nd European clinical consensus conference for device-based therapies for hypertension: state of the art and considerations for the future","volume":"38","author":"Mahfoud","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcrp.2026.200717_bib40","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1253\/circj.CJ-66-0225","article-title":"Consensus statement on renal denervation by the joint committee of JSH\/CVIT\/JCS","volume":"88","author":"Kario","year":"2024","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcrp.2026.200717_bib41","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1038\/s41440-026-02629-1","article-title":"Guidelines for the appropriate use of renal denervation systems in Japan: endorsed by JSH, CVIT, and JCS, and their positioning in the JSH 2025 guidelines","volume":"49","author":"Kario","year":"2026","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ijcrp.2026.200717_bib42","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1097\/HJH.0000000000002933","article-title":"ESH position paper on renal denervation 2021","volume":"39","author":"Schmieder","year":"2021","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ijcrp.2026.200717_bib43","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.acvd.2024.05.122","article-title":"Catheter-based renal denervation in the treatment of arterial hypertension: an expert consensus statement on behalf of the SFHTA and partner societies","volume":"117","author":"Pathak","year":"2024","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.ijcrp.2026.200717_bib44","first-page":"S559","volume":"vol. 136","author":"Zweiker","year":"2024"},{"key":"10.1016\/j.ijcrp.2026.200717_bib45","article-title":"SCAI position statement on renal denervation for hypertension: patient selection, operator competence, training and techniques, and organizational recommendations","volume":"2","author":"Swaminathan","year":"2023","journal-title":"J. Soc. Cardiovasc. Angiogr. Interv."},{"key":"10.1016\/j.ijcrp.2026.200717_bib46","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/ehjqcco\/qcae001","article-title":"Cost-effectiveness of catheter-based radiofrequency renal denervation for the treatment of uncontrolled hypertension: an analysis for the UK based on recent clinical evidence","volume":"10","author":"Sharp","year":"2024","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.ijcrp.2026.200717_bib47","article-title":"Catheter-based radiofrequency renal denervation in the United States: a cost-effectiveness analysis based on contemporary evidence","volume":"3","author":"Kandzari","year":"2024","journal-title":"J. Soc. Cardiovasc. Angiogr. Interv."},{"key":"10.1016\/j.ijcrp.2026.200717_bib48","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1111\/jch.14922","article-title":"Cost-effectiveness of radiofrequency renal denervation for uncontrolled hypertension in Japan","volume":"26","author":"Kario","year":"2024","journal-title":"J. Clin. Hypertens."},{"key":"10.1016\/j.ijcrp.2026.200717_bib49","article-title":"Cost-effectiveness of renal denervation: a systematic review and meta-analysis","author":"Anastasiou","year":"2026","journal-title":"Hypertens Res [Internet]"},{"key":"10.1016\/j.ijcrp.2026.200717_bib50","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/ehjqcco\/qcac056","article-title":"Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registry","volume":"9","author":"Schmieder","year":"2023","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.ijcrp.2026.200717_bib52","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.hipert.2024.10.003","article-title":"Physicians' perception of guideline recommendations for the treatment of resistant hypertension by renal denervation: Resistant hypertension working group, Argentine hypertension society","volume":"42","author":"Renna","year":"2025","journal-title":"Hipertens. Riesgo Vasc."},{"key":"10.1016\/j.ijcrp.2026.200717_bib53","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s40292-024-00668-8","article-title":"Management of renovascular hypertension and renal denervation in patients with hypertension: an Italian nationwide survey","volume":"31","author":"Pappaccogli","year":"2024","journal-title":"High Blood Pres. Cardiovasc. Prev."},{"key":"10.1016\/j.ijcrp.2026.200717_bib54","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/HJH.0000000000002592","article-title":"Differences in patient and physician perspectives on pharmaceutical therapy and renal denervation for the management of hypertension","volume":"39","author":"Schmieder","year":"2021","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ijcrp.2026.200717_bib55","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00392-019-01468-0","article-title":"Patient preference for therapies in hypertension: a cross-sectional survey of German patients","volume":"108","author":"Schmieder","year":"2019","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ijcrp.2026.200717_bib56","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41440-021-00760-9","article-title":"A Japan nationwide web-based survey of patient preference for renal denervation for hypertension treatment","volume":"45","author":"Kario","year":"2022","journal-title":"Hypertens. Res."},{"issue":"22","key":"10.1016\/j.ijcrp.2026.200717_bib57","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1056\/NEJMc2031173","article-title":"N-of-1 trial of a statin, placebo, or no treatment to assess side effects","volume":"383","author":"Wood","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ijcrp.2026.200717_bib58","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/ajh\/hpad013","article-title":"Nonadherence is common in patients with apparent resistant hypertension: a systematic review and meta-analysis","volume":"36","author":"Bourque","year":"2023","journal-title":"Am. J. Hypertens."}],"container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487526001479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487526001479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T07:02:43Z","timestamp":1794985363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772487526001479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":57,"alternative-id":["S2772487526001479"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcrp.2026.200717","relation":{},"ISSN":["2772-4875"],"issn-type":[{"value":"2772-4875","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal denervation beyond resistant hypertension: should drug intolerance redefine eligibility?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Cardiovascular Risk and Prevention","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcrp.2026.200717","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200717"}}